Back

Results - Announcements

Sales rise 27.18% to Rs 210.41 crore

Fredun Pharmaceuticals consolidated net profit rises 79.67% in the March 2026 quarter

29-May-2026, 01:50
Net profit of Fredun Pharmaceuticals rose 79.67% to Rs 10.78 crore in the quarter ended March 2026 as against Rs 6.00 crore during the previous quarter ended March 2025. Sales rose 27.18% to Rs 210.41 crore in the quarter ended March 2026 as against Rs 165.44 crore during the previous quarter ended March 2025.

For the full year,net profit rose 65.25% to Rs 32.62 crore in the year ended March 2026 as against Rs 19.74 crore during the previous year ended March 2025. Sales rose 40.21% to Rs 633.33 crore in the year ended March 2026 as against Rs 451.71 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	210.41	165.44	27	633.33	451.71	40
OPM %	13.73	10.43	-	13.92	12.16	-
PBDT	14.40	9.10	58	55.24	32.53	70
PBT	11.25	7.26	55	47.00	27.49	71
NP	10.78	6.00	80	32.62	19.74	65